Experimental Adaptation of Rotaviruses to Tumor Cell Lines

Area of Science:

• Virology
• Oncology
• Cancer Therapy

Background:

• Oncolytic viruses are a promising cancer treatment strategy.
• Viruses can naturally target tumor cells or be genetically modified for tumor cell infection.
• Rotaviruses are being explored for their potential as oncolytic agents.

Purpose of the Study:

• To adapt rotaviruses for enhanced tumor cell infection and oncolytic activity.
• To investigate the mechanisms of cell death induced by adapted rotaviruses.
• To explore reassortment as a method for generating novel oncolytic rotaviruses.

Main Methods:

• Multiple passages of diverse rotavirus strains (porcine, simian, bovine, human) in human tumor cell lines.
• Combination and further passaging of rotavirus isolates in tumor cell lines.
• Characterization of tumor cell death using assays for apoptosis and DNA damage (Hoechst, propidium iodide, 7-AAD, Annexin V, TUNEL, PARP, phospho-histone H2A.X).
• Analysis of electropherotype profiles to identify reassortment events.

Main Results:

• Rotavirus strains successfully adapted to infect tumor cells after multiple passages.
• Adapted rotaviruses demonstrated increased infectious capacity compared to parental strains.
• Electropherotype analysis indicated reassortment events leading to unique tumor cell-adapted isolates.
• Infection by adapted rotaviruses induced chromatin modifications consistent with apoptotic cell death.

Conclusions:

• Rotavirus adaptation through serial passaging and reassortment can enhance tumor cell infectivity.
• Tumor cell-adapted rotaviruses induce apoptosis in cancer cells, supporting their potential as oncolytic agents.
• This study highlights the feasibility of developing rotavirus-based oncolytic therapies.